Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q2)Dec 31, 2025 | (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 0 | 0 | ||||||||
| Gross profit | 0 | 0 | ||||||||
| Operating expense | -3.62%22.31K | 0.43%20.99K | 13.12%101.47K | -5.79%24.53K | 41.07%32.9K | 11.29%23.15K | 9.16%20.9K | -8.19%89.7K | -30.90%26.03K | -7.99%23.32K |
| Selling and administrative expenses | -0.84%18.49K | 0.61%18.56K | -5.47%73.84K | -72.05%6.49K | 45.54%30.25K | 10.91%18.65K | 9.23%18.45K | -2.67%78.11K | -30.87%23.22K | 2.71%20.79K |
| -General and administrative expense | -0.84%18.49K | 0.61%18.56K | -5.47%73.84K | -72.05%6.49K | 45.54%30.25K | 10.91%18.65K | 9.23%18.45K | -2.67%78.11K | -30.87%23.22K | 2.71%20.79K |
| Other operating expenses | -15.16%3.82K | -0.98%2.43K | 138.52%27.63K | 542.27%18.04K | 4.39%2.64K | 12.88%4.5K | 8.64%2.45K | -33.58%11.59K | -31.14%2.81K | -50.41%2.53K |
| Operating profit | 3.62%-22.31K | -0.43%-20.99K | -13.12%-101.47K | 5.79%-24.53K | -41.07%-32.9K | -11.29%-23.15K | -9.16%-20.9K | 8.19%-89.7K | 30.90%-26.03K | 7.99%-23.32K |
| Net non-operating interest income (expenses) | 624 | 905 | 2.08K | 833 | 1.24K | 0 | 0 | 0 | 0 | 0 |
| Non-operating interest income | --624 | --905 | --2.08K | --833 | --1.24K | --0 | --0 | --0 | --0 | --0 |
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 |
| Other net income (expenses) | 110.69%409 | -163.93%-521 | 35.45%-1.26K | 188.30%996 | 159.95%756 | -926.57%-3.83K | 290.42%815 | 5.47%-1.95K | -1.13K | -1.26K |
| Gain on sale of security | 110.69%409 | -163.93%-521 | 35.45%-1.26K | 188.30%996 | 159.95%756 | -926.57%-3.83K | 290.42%815 | 5.47%-1.95K | ---1.13K | ---1.26K |
| Income before tax | 21.13%-21.28K | -2.59%-20.6K | -9.82%-100.65K | 16.43%-22.7K | -25.70%-30.9K | -32.64%-26.98K | -2.61%-20.08K | 8.72%-91.65K | 31.65%-27.16K | 4.62%-24.58K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 21.13%-21.28K | -2.59%-20.6K | -9.82%-100.65K | 16.43%-22.7K | -25.70%-30.9K | -32.64%-26.98K | -2.61%-20.08K | 8.72%-91.65K | 31.65%-27.16K | 4.62%-24.58K |
| Net income continuous operations | 21.13%-21.28K | -2.59%-20.6K | -9.82%-100.65K | 16.43%-22.7K | -25.70%-30.9K | -32.64%-26.98K | -2.61%-20.08K | 8.72%-91.65K | 31.65%-27.16K | 4.62%-24.58K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 21.13%-21.28K | -2.59%-20.6K | -9.82%-100.65K | 16.43%-22.7K | -25.70%-30.9K | -32.64%-26.98K | -2.61%-20.08K | 8.72%-91.65K | 31.65%-27.16K | 4.62%-24.58K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 21.13%-21.28K | -2.59%-20.6K | -9.82%-100.65K | 16.43%-22.7K | -25.70%-30.9K | -32.64%-26.98K | -2.61%-20.08K | 8.72%-91.65K | 31.65%-27.16K | 4.62%-24.58K |
| Diluted earnings per share | 0 | 0 | 13.01%-0.0018 | 13.01%-0.0018 | 0 | 0 | 0 | 23.72%-0.002 | -113.35%-0.002 | 0 |
| Basic earnings per share | 0 | 0 | 13.01%-0.0018 | 13.01%-0.0018 | 0 | 0 | 0 | 23.72%-0.002 | -113.35%-0.002 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.